Cargando…
Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature
Background. Nephrogenic adenoma of the urinary bladder (NAUB) is a rare lesion associated with nonspecific symptoms and could inadvertently be misdiagnosed. Aim. To review the literature. Methods. Various internet search engines were used. Results. NAUB is a benign tubular and papillary lesion of th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897129/ https://www.ncbi.nlm.nih.gov/pubmed/27347540 http://dx.doi.org/10.1155/2015/704982 |
_version_ | 1782436093172383744 |
---|---|
author | Venyo, Anthony Kodzo-Grey |
author_facet | Venyo, Anthony Kodzo-Grey |
author_sort | Venyo, Anthony Kodzo-Grey |
collection | PubMed |
description | Background. Nephrogenic adenoma of the urinary bladder (NAUB) is a rare lesion associated with nonspecific symptoms and could inadvertently be misdiagnosed. Aim. To review the literature. Methods. Various internet search engines were used. Results. NAUB is a benign tubular and papillary lesion of the bladder, is more common in men and adults, and has been associated with chronic inflammation/irritation, previous bladder surgery, diverticula, renal transplantation, and intravesical BCG; recurrences and malignant transformations have been reported. Differential diagnoses include clear cell adenocarcinoma, endocervicosis, papillary urothelial carcinoma, prostatic adenocarcinoma of bladder, and nested variant of urothelial carcinoma; most NAUBs have both surface papillary and submucosal tubular components; both the papillae and tubules tend to be lined by a single layer of mitotically inactive bland cells which have pale to clear cytoplasm. Diagnosis may be established by using immunohistochemistry (positive staining with racemase; PAX2; keratins stain positive with fibromyxoid variant), electron microscopy, DNA analysis, and cytological studies. Treatment. Endoscopic resection is the treatment but recurrences including sporadic malignant transformation have been reported. Conclusions. There is no consensus on best treatment. A multicentre study is required to identify the treatment that would reduce the recurrence rate, taking into consideration that intravesical BCG is associated with NAUB. |
format | Online Article Text |
id | pubmed-4897129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-48971292016-06-26 Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature Venyo, Anthony Kodzo-Grey Int Sch Res Notices Review Article Background. Nephrogenic adenoma of the urinary bladder (NAUB) is a rare lesion associated with nonspecific symptoms and could inadvertently be misdiagnosed. Aim. To review the literature. Methods. Various internet search engines were used. Results. NAUB is a benign tubular and papillary lesion of the bladder, is more common in men and adults, and has been associated with chronic inflammation/irritation, previous bladder surgery, diverticula, renal transplantation, and intravesical BCG; recurrences and malignant transformations have been reported. Differential diagnoses include clear cell adenocarcinoma, endocervicosis, papillary urothelial carcinoma, prostatic adenocarcinoma of bladder, and nested variant of urothelial carcinoma; most NAUBs have both surface papillary and submucosal tubular components; both the papillae and tubules tend to be lined by a single layer of mitotically inactive bland cells which have pale to clear cytoplasm. Diagnosis may be established by using immunohistochemistry (positive staining with racemase; PAX2; keratins stain positive with fibromyxoid variant), electron microscopy, DNA analysis, and cytological studies. Treatment. Endoscopic resection is the treatment but recurrences including sporadic malignant transformation have been reported. Conclusions. There is no consensus on best treatment. A multicentre study is required to identify the treatment that would reduce the recurrence rate, taking into consideration that intravesical BCG is associated with NAUB. Hindawi Publishing Corporation 2015-02-02 /pmc/articles/PMC4897129/ /pubmed/27347540 http://dx.doi.org/10.1155/2015/704982 Text en Copyright © 2015 Anthony Kodzo-Grey Venyo. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Venyo, Anthony Kodzo-Grey Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature |
title | Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature |
title_full | Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature |
title_fullStr | Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature |
title_full_unstemmed | Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature |
title_short | Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature |
title_sort | nephrogenic adenoma of the urinary bladder: a review of the literature |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897129/ https://www.ncbi.nlm.nih.gov/pubmed/27347540 http://dx.doi.org/10.1155/2015/704982 |
work_keys_str_mv | AT venyoanthonykodzogrey nephrogenicadenomaoftheurinarybladderareviewoftheliterature |